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Infantile juvenile polyposis is a rare disease with severe gastrointestinal
symptoms and a grave clinical course. Recently, 10q23 microdeletions
involving the PTEN and BMPR1A genes were found in four patients
with infantile juvenile polyposis. It was hypothesized that a combined
and synergistic effect of the deletion of both genes would explain the
condition. Subsequently, however, a patient with a larger 10q23 deletion
including the same genes but with a mild clinical phenotype was
identified. Here, we present four additional patients with 10q23
microdeletions involving the PTEN and BMPR1A genes. The sizes of the
deletions were analyzed using single nucleotide polymorphism array
analysis. All patients had macrocephaly, dysmorphic features,
retardation and congenital abnormalities. One patient developed
colorectal cancer. However, only one case had disease onset before
2 years of age and severe symptoms requiring colectomy. No clear
correlation was found between ages at onset or severity of
gastrointestinal symptoms and the sizes of the deletions. We conclude
that patients with 10q23 microdeletions involving the PTEN and
BMPR1A genes have variable clinical phenotypes, which cannot be
explained merely by the deletion sizes. The phenotypes are not restricted
to severe infantile juvenile polyposis but include childhood-onset cases
with macrocephaly, retardation, mild gastrointestinal symptoms and
possibly early-onset colorectal cancer.
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Juvenile polyps are defined by their microscopic
appearance: they show abundant stroma com-
posed of inflamed, often edematous granulation
tissue that surrounds cystically dilated glands
containing mucus (1). A single juvenile polyp in
the distal colorectum is a common cause of rectal
bleeding in children. In contrast, juvenile polypo-
sis, defined by the occurrence of multiple juvenile
polyps, is rare and occurs in a heterogeneous group
of conditions, including juvenile polyposis syn-
drome’ (JPS) and PTEN hamartoma syndrome’.
JPS (OMIM 174900) is clinically defined by ex-
clusion of syndromes with multisystem involve-
ment. Criteria for the diagnosis are more than
five juvenile polyps in the colorectum, or juvenile
polyps throughout the gastrointestinal tract, or any
number of juvenile polyps with a family history of
juvenile polyposis (1). JPS may be due to germline
mutations in the SMAD4 (18q21.1) or BMPR1A
(10q23.2) genes (2). The related group of syn-
dromes characterized by juvenile polyposis and
multisystem involvement is largely due to PTEN
germlinemutations (10q23). The associated clinical
disorders are Cowden disease (OMIM 158350),
Lhermitte–Duclos disease, Bannayan–Riley–
Ruvalcaba syndrome (BRRS, OMIM 153480)
and Proteus/Proteus-like syndrome, now grouped
together as PTEN-hamartoma syndrome (3).
All forms of juvenile polyposis usually present
initially in older children or young adults. How-
ever, rare patients with infantile juvenile polyposis
have been describedwho presented in the first year
of life with severe gastrointestinal symptoms,
including diarrhea, intestinal bleeding, protein-
losing enteropathy and intussusception. Many of
these patients, in addition, had congenital abnor-
malities, in particular macrocephaly and general-
ized hypotonia. Usually, their clinical course was
severe, leading to death in early childhood. An
autosomal recessive inheritance pattern has been
proposed for this condition (4–11).
Recently, Delnatte et al. (12) presented four pa-
tients with infantile juvenile polyposis and a 10q23
microdeletion involving both the PTEN and the
BMPR1A genes. These authors hypothesized that
infantile juvenile polyposis may not be due to
autosomal recessive inheritance but, instead, to
a combined and synergistic effect of the deletion
of both the PTEN and the BMPR1A genes. Sub-
sequently, however, Salviati et al. (13) presented
a patient with a 10q23 deletion of larger size than
those described by Delnatte et al. (12). The dele-
tion again involved both genes but with a mild
clinical phenotype without the severe gastrointes-
tinal symptoms of infantile juvenile polyposis.
Here, we present four additional patients with
10q23 microdeletions encompassing both the
BMPRIA and the PTEN genes. We describe the
sizes of the deletions determined by single nucleo-
tide polymorphism (SNP) array analysis. In one
case with a combined PTEN and BMPR1A
defect, early-onset colorectal cancer was docu-
mented.
Clinical data
Case 1 is the second child of healthy, non-consan-
guineous Moroccan parents. He was born at term
after a normal pregnancy and an uneventful deliv-
ery with a birth weight of 3850 g. Congenital
abnormalities were present including macroce-
phaly (39 cm, 13 SD) and mild dysmorphic fea-
tures: low-set ears, telecanthus, eye proptosis, and
a long philtrum. There was generalized hypotonia.
No abnormal penile pigmentation was observed.
Perimembranous and muscular ventricular septal
defect with left superior vena cava was diagnosed.
An episode of cardiac failure occurred at the age
of 6 months. The septal defects closed spontane-
ously. Grossmotor and speech–language develop-
ment were delayed – motor milestones included
sitting at 12 months and walking without support
at 28 months. The macrocephaly was progressive
(55.5 cm, 15 SD at 14 months). Neurological
examination at the age of 2.5 years showed poor
maturation of gross and fine motor performance,
delay in emotional and cognitive behavior and
generalized hypotonia. There was no history of
epilepsy. Magnetic resonance imaging (MRI) of
the brain showedmegalencephaly, dysplastic cere-
bral ventricles and persistent septum pellucidum
and cavum vergae. No hydrocephalus or focal ab-
normalities of the cerebral architecture were noted.
Diarrhea with bloody stools began at the age of
2 years. Colonoscopy performed at the age of
3 years showed multiple pedunculated polyps
throughout the large bowel and in between hun-
dreds of small elevations that had the appearance
of developing polyps. The five largest polyps were
removed. Histological examination showed juve-
nile characteristics. Upper gastrointestinal tract
endoscopy showed several sessile polyps at the
pylorus and in the proximal duodenum. Video cap-
sule enteroscopy and MRI enteroclysis showed
mild duodenal polyposis and extensive small bowel
involvement (Fig. 1).
The family history was negative for any of the
clinical signs found in the proband.
Case 2 is the first male child of healthy parents,
the father and mother being of Turkish and Ira-
nian origin, respectively. At the age of 5 months,
he was admitted to hospital because of dehydra-
tion attributed to gastrointestinal infection. The
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patient had macrosomia, length, weight and head
circumferences being 2 SD above the mean. At
follow-up, the main clinical features were a large
head, mild dysmorphic features, mild mental and
motor delay, and hypotonia. At the age of
18 months, watery diarrhea occurred that led to
a second hospital admission. Colonoscopy re-
vealed juvenile polyposis of the large bowel. At
radiological examination, no small bowel polyps
were detected. Because of persistent diarrhea,
rectal blood loss, anemia and hypoalbuminemia,
subtotal ileocolectomy was performed at the age
of 23 months. The surgical specimen of 80-cm
length showed an enormous number of polyps,
with diameters varying from several millimeters
to 3.3 cm. A large number of these polyps were
spherical and pedunculated. The 3-cm part of the
ileum resected also contained multiple polyps.
Histologically, the polyps showed juvenile charac-
teristics without features of dysplasia. Physical
examination at follow-up at the age of 2 years,
previously described by Hendriks et al. (14),
showed a hypotonic boy with motor delay. Height
and head circumference (54 cm) were above the
97th percentile. His ears were low set and posteri-
orly rotated. A slight downslant of the eyes was
noticed. His philtrum appeared long and his
mouth broad. A hemangioma was noted on the
thorax. The glans penis could not be examined due
to phimosis.
The family history was unremarkable although
incomplete. A paternal brother possibly had
a mental handicap.
Case 3, a girl, was born at term to unrelated
parents from southern Belgium. A heart murmur
was caused by a ventricular septal defect.
Repeated urinary infections due to vesicoureteral
reflux necessitated reimplantation of the ureters.
At the age of 10 months, a cleft palate was treated
surgically. No skin abnormalities were recorded.
Psychomotor development was delayed; walking
without assistance began at 20 months and there
was no speech development at the age of 4 years.
At that age, persistent anemia led to further eval-
uation. Colonoscopy showed numerous polyps
throughout the large bowel.At colonoscopy 1 year
later, a great number of polyps was observed,
more than 15 at all levels. At upper gastrointesti-
nal endoscopy, several polyps were observed in
the gastric fundus, duodenum and jejunum; some
had confirmed juvenile histology. At 6 years of
age, lung alveolitis was diagnosed and treatedwith
corticosteroids. The patient is presently 16 years
of age and is generally doing well. She has macro-
cephaly and mild mental retardation. Recently, at
repeat colonoscopy, several dozens of colorectal
juvenile polypswere found, some of which showed
features of low-grade dysplasia. The family his-
tory in this case was unremarkable.
Case 4 is a patient with mental retardation and
remarkable macrocephaly. At the age of 5 years,
he was described as having an exceptionally large
head that continued to grow well above the 98th
percentile. He was a rather short child, being on
the third percentile for height with a slightly
coarse facies and generalized hypotonia. The
Fig. 1. Case 1. Images obtained dur-
ing colonoscopy (a and b), video
capsule enteroscopy (c) and mag-
netic resonance enteroclysis (d) and
polyp histology on hematoxylin–
eosin staining (e).
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patient’s intellectual capacity was significantly de-
layed. No hemangiomas or other skin lesions were
present. Early puberty, kyphosis and an unusual
skin condition described as being akin to mor-
phoeawere recorded.At the age of 24 years, rectal
cancer and liver metastases were diagnosed. The
patient presented with weight loss, anorexia and
rectal bleeding and was found to have a large pol-
ypoidal obstructing tumor in the rectum. Thus,
the rest of the bowel was not visualized. Biopsy
of the tumor confirmed a moderately differenti-
ated adenocarcinoma. A palliative ileostoma was
created but no other treatment was felt appropri-
ate. A contrast-enhanced computed tomography
(CT) confirmed a bulky and extensive circum-
ferential thickening of rectum extending up to
mid-sigmoid colon, with extensive infiltration of
surrounding mesorectal fat, but the tumor did not
definitely extend to involve mesorectal fascia.
Local, para-aortic and aortocaval lymphadeno-
pathy was noted and extensive hepatic metastases
were identified. It was not possible to assess the
remainder of the bowel with any degree of cer-
tainty due to the marked fecal loading. In conclu-
sion, the patient had a very bulky rectosigmoid
tumor, staged on CT san as T3N2M1. Thus,
unfortunately, no information on the rest of the
bowel was available as the patient never had a lap-
arotomy or colonoscopy due to the obstructing
and metastatic nature of his primary tumor. The
patient died at the age of 25 years.
The patient had two healthy younger siblings.
Both parents were healthy, of normal intelligence
and not dysmorphic. No genetic testing could be
performed in the parents.
The patient’s family history was negative for
colorectal cancer in first- and second-degree
family members.
Molecular studies
Because all four patients showed developmental
delay and features ofPTENhamartoma syndrome,
routine chromosome analysis (resolution 600
bands) and DNA sequence analysis of the PTEN
gene were performed. Additionally, fluorescence in
situ hybridization (FISH) using different probes
for bands 10q23.2 to 10q23.31 and multiplex
ligation-dependent probe amplification (MLPA)
analysis (15) of the PTEN and BMPR1A genes
were performed. For this, the SALSA MLPA Kit
P158 Juvenile Polyposis (MRC-Holland, Amster-
dam, the Netherlands) was used. Information
regarding the number and distribution of the dif-
ferent gene probes is given in Fig. 2 (see also
http://www.mlpa.com/pages/p158pag.html).
Genotype software allowed determination of the
peak height for each polymerase chain reaction
product; these data were entered into a spread-
sheet developed using Microsoft Excel. Data
were normalized by dividing each individual peak
height by the average of all the autosomal peak
heights for the sample. The normalized peak value
thus obtained was divided by the average peak
height of the same fragment of all control samples
within the experiment. Probes with too high a var-
iation between control individuals were excluded.
Further characterization of the deletions was
achieved by SNP analysis using the Affymetrix
250k NspI array, which contains 25-mer oligonu-
cleotides representing a total of 262,264 SNPs.
The SNParray experimentwas performed accord-
ing to protocols provided by the manufacturer
(Affymetrix, Inc., Santa Clara, CA). Copy num-
ber estimates were determined using the updated
version 2.0 of the CNAG (Copy Number Analyzer
for Affymetrix GeneChip mapping) software
package (16). The normalized ratios were subse-
quently analyzed for genomic imbalances by
a standard hidden Markov model, essentially as
described by de Vries et al. (17). The SNP array
data obtained from patient DNA were compared
with SNP array data from multiple healthy sex-
matched individuals.
Results
In all four patients, routine chromosome analysis
andDNA sequence analysis of thePTEN gene did
not reveal any abnormalities.
In Case 1, the loss in 10q23 initially identified by
FISH (data not shown) was confirmed by region-
specific MLPA analysis (Fig. 2) and further
characterized by SNP array analysis (Fig. 3).
The deletion was de novo and appeared to be
2.88 Mb in size (260 SNPs). The deleted region in-
volves 31 known genes, including BMPR1A and
PTEN, with the proximal breakpoint at 88.30 Mb
in front of LDB3 (10q23.2) and the distal break-
point at 91.18 Mb in SLC16A12 (10q23.31).
The loss in 10q23 in Case 2 was identified by
MLPA analysis. Upon SNP array analysis
(Fig. 3), it appeared to be 4.26 Mb in size (434
SNPs). This deleted region harbors 38 known
genes, including PTEN and BMPR1A, with the
proximal breakpoint between 88.46 and 88.49 Mb
in LDB3 (10q23.2) and the distal breakpoint at
92.72 Mb close to ANKRD1 (10q23.31). Genetic
testing in the parents could not be performed.
The 10q23microdeletion in Case 3 was observed
upon MLPA and appeared to be 3.55 Mb in size
(317 SNPs), with the proximal breakpoint at
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86.52 Mb (10q23.2) and the distal breakpoint at
90.07 Mb in BC005364 (10q23.31). The de novo
deleted region in this patient contains PTEN and
BMPR1A and 15 other known genes.
In Case 4, a combined PTEN and BMPR1A
deletion was detected upon MLPA analysis. The
deletion was subsequently confirmed by SNP
array analysis and appeared to be 4.01 Mb in size
(390 SNPs). The proximal and distal breakpoints
are at 86.83 Mb (10q23.1) and 90.84 Mb
(10q23.31), respectively.
In Fig. 4, the fully characterized deletions in
10q23 of Cases 1–4 identified in this study and four
patients identified in previous studies are depicted
schematically. The overlapping regiondeleted in all
eight patients is further delineated proximally by
Case C and distally by Case 3, making PTEN the
most distal deleted gene. This region is 1.47 Mb in
size and contains a total number of 10 genes, in-
cluding PTEN and BMPR1A as well asMMRN2,
SNCG, C10orf116, GLUD1, FAM35A, MINPP1,
PAPSS2 and ATAD1.
Discussion
Juvenile polyposis, the occurrence of multiple pol-
yps with juvenile histology, is a rare group of con-
ditions, heterogeneous with regard to clinical
picture and underlying cause. Sachatello et al.
(9) proposed infantile juvenile polyposis’ to be
a separate clinical entity based on the patient they
reported and six cases described previously. These
authors defined infantile juvenile polyposis as
being characterized by gastrointestinal bleeding,
diarrhea, recurrent rectal prolapse, inanition,
and intussusception in infants. The authors
emphasized that six of seven infants with exten-
sive juvenile polyposis died before age 2 years’.
The data of the patients described by Sachatello
et al. (9), five previous cases (4–8) and two sub-
sequent cases (10, 11) are summarized in Table 1.
In all these patients, the family history for poly-
posis was negative.
The more recently described cases with infantile
and childhood-onset juvenile polyposis were sub-
jected to detailed chromosomal and molecular
analysis, summarized in Table 2, and now, adding
the case histories of four such patients in this
report, we can compare the eight patients in whom
the sizes of the 10q23 deletions were analyzed in
detail, schematically depicted in Fig. 4.
Among these patients, the clinically severe
group as defined by requiring colectomy are pa-
tients B, C and Case 2. Apparently, there is no
clear correlation between deletion size and pheno-
type in these eight patients.
In recent literature, there has been renewed dis-
cussion on the definition of juvenile polyposis of
infancy. Salviati et al. (13) stated that our patient
did not have any of the features of juvenile poly-
posis of infancy, i.e. onset before age 2 years,
severe bleeding, diarrhea, protein-losing enterop-
athy, inanition, and rectal prolapse’. For this def-
inition, the authors refer to Sachatello et al. (9).
Sanlaville et al. (18) state that by operational
definition, juvenile polyposis in patients younger
than 6 years may be classified as ‘‘juvenile poly-











































































































































neg ctrl_1 neg ctrl_2
neg ctrl_3 neg ctrl_4
pos ctrl PTEN_1 pos ctrl PTEN_2
pos ctrl PTEN_3 Case 1
Case 2 Case 3
Case 4
Fig. 2. Copy numbers of the PTEN and BMPR1A genes. Copy numbers of the PTEN and BMPR1A genes in patients with
a PTEN deletion (pos ctrl PTEN_1-3) or a combined deletion of PTEN and BMPR1A (Cases 1–4) and that of control
individuals (neg ctrl) were determined using multiplex ligation-dependent probe amplification (MLPA) analysis. For this,
probes complementary to the indicated chromosomal regions and (parts) of the indicated gene exons (e) within the SALSA
MLPA Kit P158 (MRC Holland) have been used. MLPA signals were quantified and normalized to the probes in the control
chromosomal regions and control individuals.
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aspects are considered: the age of onset and the
type and severity of clinical signs and symptoms.
We conclude that within the group of early-onset
juvenile polyposis, infantile juvenile polyposis’
seems to stand out as a separate entity not only
by its very early onset (before the age of 2 years)
but also by the above-described severe clinical
signs. Some cases with PTEN plus BMPR1A dele-
tions have this clinical picture, while others do not.
Previous authors (13, 18) have proposed several
possible mechanisms to explain the clinical differ-
ences between patients with 10q23microdeletions.
Because in patients with a severe phenotype, the
deletions occurred both on paternal and onmater-
nal chromosomes, the paternal origin of the dele-
tion apparently did not play an important role.
We now have identified the proximal and distal
breakpoints for each patient using SNP array
analysis. The proximal breakpoints of the milder
group lie between 82.1 and 88.3 Mb, whereas the
severe group has proximal breakpoints between
88.42 and 88.62 Mb. Therefore, at least in theory,
the presence of the region between 88.30 and
88.42 Mb may be associated with a more severe
clinical phenotype. However, the possible role of
the promoter of LDB3 and the eye-specific OPN4
gene, which are located in this region, remains
elusive. There seems to be no relationship between
the position of the distal breakpoints and the
severity of the disease.
The overlapping region deleted in all eight pa-
tients subjected to SNP analysis is 1.47 Mb wide
and includes a total number of 10 genes, including
PTEN and BMPR1A as well asMMRN2, SNCG,
C10orf116,GLUD1,FAM35A,MINPP1,PAPSS2
and ATAD1.
Little is known about the function of these genes
and their possible role in human disease.
MINPP1, which presumably plays a role in cell
differentiation and apoptosis, was studied in pa-
tients with Cowden and BRRS without germline
PTEN mutations. No MINPP1 germline muta-
tions were found (19).
An important question is the risk for gastroin-
testinal malignancies in these patients with 10q23
microdeletions. Both PTEN and BMPR1Amuta-
tions have been associatedwith juvenile polyposis,
whereas BMPR1A mutations also have been
found in patients with a histologically mixed form
of polyposis (20). Two of the patients described by
Delnatte et al. (12) had adenomatous polyps,
while in one of these patients, an adenocarcinoma
in a polyp was found. Therefore, the authors con-
sidered the cancer risk for this group of patients to
Fig. 3. Plot of chromosome 10 after single nucleotide polymorphism (SNP) analysis on DNA from patients 1, 2, 3 and 4. In
the upper panel (a), the log2 test over reference ratio is plotted on the y-axis vs the genomic position on chromosome 10
represented by the idiogram on the x-axis in the lower part of the figure. Each dot represents the value for a certain SNP. The
normal ratio with value 0 is indicated by the solid, horizontal blue line. Values for normal ratios range between 20.38 and
10.3. Values outside this range are considered abnormal. In panel (b), each measure point represents the average value of 10
neighboring SNPs. The loss in 10q23 is detected by the significantly lowered ratios shown in panels a and b (black arrow).
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be major. Probably, the cancer risk is largely
dependent on the number and type of polyps found
in each individual patient. The remarkable patient
whomwedescribe in this report (Case 4)hadmacro-
cephaly, retardation and no obvious gastrointes-
tinal symptoms until the age of 24 years when
rectal cancer with liver metastasis was noted.
For this patient, a causal relationship between
the chromosomal defect and the rectal cancer
has not been proven. No additional data on
Fig. 4. Schematic representation of the deletion in chromosome 10q23 in patients described in previous studies (A–D) and
this study (Cases 1–4). Patients A, B, C and D have been described by Salviati et al. (13) (A), Delnatte et al. (12) (B and C) and
Tsuchiya et al. (23) (D). However, it should be noted that patients B and C are not the patients 1 and 2 reported by Delnatte
et al. (12), as quoted by Salviati et al. (13); instead, B and C are patients 2 and 1, respectively. The respective deletion start and
end points are 82.1–94.4 Mb (patient A), 88.4–90.4 Mb (patient B), 88.6–90.7 Mb (patient C), 87.8–92.5 Mb (patient D),
88.30–91.18 Mb (Case 1), 88.46–92.72 Mb (Case 2), 86.52–90.07 Mb (Case 3) and 86.83–90.84 Mb (Case 4). The losses in
10q23 are schematically indicated by the red rectangle in the idiogram. The overlapping deleted region is indicated by the
purple rectangle and includes a total of 10 genes: BMPR1A, MMRN2, SNCG, C10orf116, GLUD1, FAM35A, MINPP1,
PAPSS2, ATAD1 and PTEN.
Table 1. Previous reports on eight patients with infantile juvenile polyposis
M/F
Juvenile polyposis Other clinical signs Treatment and follow-up
ReferenceU/L D/E
Age at
onset Macr Dysm Retard Others Surgery Follow-up
M 1/1a 1 4 months Polypectomies Died at 6 months (4)
M 1/1 1 9 months 1 2 1 Alopecia, clubbing,
hepatosplenomegaly
and hypotonia
Subtotal colectomy Died at 16 months (5)
M 1/1 1 6 weeks Hepatomegaly Laparotomies Died at 16 months (6)
M 1/1 1 3 months 1 1 Laparotomies Died at 18 months (7)
M 1/1 9 months 2 Colectomy Polyps at 16 years (8)
F 1/1 1 1 month 1 Clubbing, heart defect
and hepatomegaly
Colectomy Died at 22 months (9)
M 1/1 1 6 months 1 Alopecia, clubbing,
hepatomegaly and
hypotonia
Ileostomy Died at 16 months (10)
M 2/1 1 13 months 1 Laparotomy Recovered (11)
D/E, (bloody) diarrhea and/or protein-losing enteropathy; Dysm, facial dysmorphism; F, female; M, male; Macr, macrocephaly;
Retard, psychomotor retardation; U/L, juvenile polyposis in upper/lower gastrointestinal tract.
aHistological type of polyps not clearly described.






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































gastrointestinal pathology (the presence or
absence of polyposis) are available. Molecular
analysis of the tumor did not indicate a mismatch
repair defect. In the context of the other data, the
malignancy may well be due to the 10q23 micro-
deletion.
Recently, additional patients with combined
PTEN and BMPR1A deletions identified by
MLPA analysis have been reported (21, 22). One
of these cases had thyroid cancer, underlining the
variability of clinical phenotypes for this group of
patients.
As indicated in Tables 1 and 2, several patients
with 10q23 deletions have had heart defects. These
defects were mostly atrial and/or ventricular sep-
tal defects but also included left superior vena
cava, tricuspid insufficiency, dysplasia of the pul-
monary valve, and atresia of the portal vein. These
defects may well be associated with the complex
genetic alterations involved in chromosomal mi-
crodeletions and not be due to a single gene defect.
The current possibilities of DNA-based diagno-
sis have led to new classifications of many syn-
dromes and may now shed new light upon
infantile and childhood-onset forms of juvenile
polyposis. Deletion analysis seems to be war-
ranted in patients with clinical pictures associated
with PTEN and BMPR1A mutations, in particu-
lar juvenile polyposis, histologically mixed forms
of polyposis and macrocephaly. For diagnostic
purposes, gene-specific deletion analyses, such as
MLPA, would be adequate. However, if a detailed
analysis of breakpoint boundaries is required,
array CGH would be the method of choice.
We conclude that patients with 10q23 microdele-
tions involving the PTEN and BMPR1A genes
have variable clinical phenotypes, which are largely
independent of the deletion size. Moreover, the
phenotypes are not restricted to severe infantile
juvenile polyposis but include childhood-onset
caseswithmacrocephaly, retardation andmild gas-
trointestinal symptoms and possibly early-onset
colorectal cancer and other malignancies.
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